News and Press Releases
Capsida Announces AbbVie Opt-in for First Genetic Medicine Program from Neurodegenerative Disease Collaboration
Capsida to receive a $40 million license payment and is eligible for additional milestones and royalties 7 January 2025 -- California, US -- Capsida Biotherapeutics today announced that AbbVie has...
Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: January 7, 2025
Alzheon Announces Appointment of Renowned Investor and Financial Executive Muneer A. Satter to Board of Directors
Mr. Satter’s Extensive Investment, Company-Building, and Transaction Experience Strengthens Alzheon’s Board Leadership Valiltramiprosate/ALZ-801 Has Potential to Become the First Oral Agent to Slow Alzheimer’s Pathology in Patients APOLLOE4 Pivotal Phase...
Category: Biotechnology, Clinical Trials, Drug Discovery, Pharmaceutical
Posted: January 7, 2025
IDDI Announces New Leadership to Drive Growth and Innovation
Tim Davis appointed as new Chief Executive Officer and Jeremy Edwards named the new Chief Commercial Officer 7 January 2025 -- Ottignies, Belgium -- International Drug Development Institute (IDDI), a...
Category: Clinical Trials, Other, Pharmaceutical
Posted: January 7, 2025
Merck launches first-to-market, cyber-physical trust platform to tackle issues of product safety and counterfeiting
M-Trust™ is a secure cyber-physical trust platform that enables the creation of digital twins for enhanced product quality and authenticity assurances This cutting-edge new technology is being unveiled at CES...
Category: Biotechnology, Logistics, Other, Pharmaceutical
Posted: January 7, 2025
1 rue Jacques Monod, Site Montesquieu, 33650 Martillac, France
Gaelic Laboratories announces expansion enabling access to growing Middle East pharma market
Gaelic Laboratories, a European CMO based in Ireland, has established a subsidiary in the UAE, enabling access to the Middle East market – both for Gaelic Laboratories and its marketing...
Category: Biotechnology, Drug Discovery
Posted: January 6, 2025
Old Waterford Rd, Gurtnafleur, Clonmel, Co. Tipperary, E91 CD92 Ireland
Santhera Enters into Supply and Distribution Agreement for AGAMREE (Vamorolone) with Clinigen Group
6 January 2025 -- Pratteln, Switzerland -- Santhera Pharmaceuticals announces the signing of an exclusive agreement with Clinigen Group to manage the supply and distribution of AGAMREE (vamorolone) in countries...
Category: Logistics, Manufacturing and Packing, Other, Pharmaceutical
Posted: January 6, 2025
Santhera Pharmaceuticals Headquarters Hohenrainstrasse 24 | 4133 Pratteln | Switzerland
Neumora Therapeutics Reports Data from KOASTAL-1 Study of Navacaprant in Major Depressive Disorder
Study did not demonstrate statistically significant improvement on primary endpoint of reduction in depressive symptoms as measured by MADRS total score compared to placebo Navacaprant showed an efficacy signal in...
Category: Biotechnology, Clinical Trials, Drug Discovery, Pharmaceutical
Posted: January 2, 2025
Certa Therapeutics Expands GPR68 Platform through Acquisition of OccuRx
Strengthened Pipeline Targets Multiple Fibrotic Diseases 19 December 2024 -- Melbourne, Australia -- Certa Therapeutics (Certa), a biotechnology company developing innovative precision therapies for patients with fibrotic diseases, today announces...
Category:
Posted: December 20, 2024
Pharmapack Announces 2025 Pharmapack Award Finalists
Finalists Span Eight Categories Celebrating Innovation, Sustainability, and Inclusivity in Pharmaceutical Packaging 13 December 2024 – Paris, France – Pharmapack Europe – the event at the heart of pharma’s packaging and...
Category: Pharmaceutical
Posted: December 19, 2024
Paris Expo, Porte de Versailles - Hall 7.2 | Paris, France
Nxera Pharma and Shionogi Launch QUVIVIQ™ in Japan for Adults with Insomnia
19 December 2024 – Tokyo, Japan and Cambridge, UK, – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) – formerly known as Sosei Group or Sosei Heptares –...
Category: Drug Delivery, Drug Discovery
Posted: December 19, 2024
Italian roots, global reach: Biotech investment insights — a dynamic conversation with Graziano Seghezzi and Francesco De Rubertis
Get ready to ignite your BIO- Europe Spring 2025 experience with Graziano Seghezzi of Sofinnova Partners and Francesco De Rubertis of Medicxi, as they take the stage to set the...
Category: Other
Posted: December 19, 2024
CCIB Barcelona Plaça de Willy Brandt 11-14 08019 Barcelona Spain
Bioxodes meets enrollment milestone in Phase 2a intracerebral hemorrhagic stroke trial
Bioxodes has enrolled first 16 patients in trial with BIOX-101 Completing treatment of first cohort of patients will trigger interim analysis BIOX-101 is a first-in-class drug candidate, a peptide developed...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: December 19, 2024
Etihad Cargo adds paris to freighter network with new weekly service
Etihad Cargo will launch a weekly freighter service to Paris Charles de Gaulle Airport (CDG) starting 7 January 2025, adding over 100 tonnes of capacity and becoming the 12th destination...
Category: Logistics
Posted: December 19, 2024
Fair Trade Capsules Mark Launched: HPMC Manufacturers Urged to Adopt or Risk Losing Consumer Trust
New mark offered to manufacturers willing to embrace transparency, addressing consumer concerns over ethics in capsule production. EMBOCAPS, a leader in ethical capsule manufacturing, has launched the Fair Trade Capsules...
Category: Manufacturing and Packing
Posted: December 18, 2024
Johnson & Johnson submits application to the European Medicines Agency seeking approval of a new indication for IMBRUVICA® (ibrutinib) in adult patients with previously untreated mantle cell lymphoma (MCL) who are eligible for autologous stem cell transplant
The European MCL Network Phase 3 TRIANGLE study, evaluated ibrutinib in combination with induction immunochemotherapy, both with and without an autologous stem cell transplant, followed by 24 months fixed-duration ibrutinib...
Category: Drug Discovery, Pharmaceutical
Posted: December 18, 2024
Janssen-Cilag Limited 50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG
